Kapak Resmi

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo

Mu opioid receptors modulate a large number of physiological functions. They are in particular involved in the control of pain perception and reward properties. They are also the primary molecular target of opioid drugs and mediate their beneficial analgesic effects, euphoric properties as well as n...

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Muzeyyen Ugur (Yazar), Lyes Derouiche (Yazar), Dominique Massotte (Yazar)
Materyal Türü:	Kitap
Baskı/Yayın Bilgisi:	Frontiers Media S.A., 2018-11-01T00:00:00Z.
Konular:	article
Online Erişim:	Connect to this object online.
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Functional selectivity of EM-2 analogs at the mu-opioid receptor
Yazar:: Justyna Piekielna-Ciesielska, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
Yazar:: Keith M. Olson, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Mu-opioid receptor expression in multibacillary leprosy
Yazar:: Patrícia Elizabeth Pignataro, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
Yazar:: Wentworth Sean, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors
Yazar:: Carlo Matera, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Basic evidence for class A G-protein-coupled receptor heteromerization
Yazar:: Rafael eFranco, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
Yazar:: Zachary W. Reichenbach, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

It's MORe exciting than mu: Crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system
Yazar:: Elena H Chartoff, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Interfering amino terminal peptides and functional implications for heteromeric gap junction formation
Yazar:: Richard David Veenstra, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Erratum: Interfering amino terminal peptides and functional implications for heteromeric gap junction formation
Yazar:: Eric C Beyer, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
Yazar:: Pergolizzi JV Jr, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
Yazar:: Joshua C. Zamora, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Functional differences in the mu opioid receptor SNP 118A>G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin
Yazar:: Casey Patrick, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment
Yazar:: Imen CHATTI, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl
Yazar:: Xiangyun Tian, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Yazar:: Li Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Type 2β Corticotrophin Releasing Factor Receptor Forms a Heteromeric Complex With Dopamine D1 Receptor in Living Cells
Yazar:: Hector E. Yarur, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
Yazar:: Roberta Lattanzi, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis
Yazar:: Jia-Jia Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
Yazar:: Alba Vidal-Torres, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking β-arrestin 2
Yazar:: Hales Tim G, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent
Yazar:: Tay GK, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Differential effects of glucose‐dependent insulinotropic polypeptide receptor/glucagon‐like peptide‐1 receptor heteromerization on cell signaling when expressed in HEK‐293 cells
Yazar:: Bashaier Al‐Zaid, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid  dependence: A meta-analysis
Yazar:: Janet K Coller, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons - Effects of Nerve Injury
Yazar:: Philip Stötzner, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

In Vivo Regulation of the μ Opioid Receptor: Role of the Endogenous Opioid Agents
Yazar:: Veronica Gonzalez-Nunez, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference with heteromer formation
Yazar:: Xianlong Gao, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implicationsCapsule Summary
Yazar:: Sarina Elmariah, MD, PhD, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

The role of opioid receptors in modulating Alzheimer's Disease
Yazar:: Parthasaradhireddy Tanguturi, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients-A Critical Review
Yazar:: Michael Soyka
Baskı/Yayın Bilgisi: (2021)

Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1
Yazar:: Pasternak Gavril W, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Fluorescent knock-in mice to decipher the physiopathological role of G protein-coupled receptors.
Yazar:: Dominique eMassotte, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Association between single nucleotide polymorphisms in the mu opioid receptor gene (<it>OPRM1</it>) and self-reported responses to alcohol in American Indians
Yazar:: Wilhelmsen Kirk C, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Spatiotemporal Up-Regulation of Mu Opioid Receptor 1 in Striatum of Mouse Model of Huntington's Disease Differentially Affecting Caudal and Striosomal Regions
Yazar:: Ryoma Morigaki, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Pharmacological Differences between Native Homomeric Transient Receptor Potential Canonical Type 4 Channels and Heteromeric Transient Receptor Potential Canonical Type 1/4 Channels in Lateral Septal Neurons
Yazar:: Kevin D. Phelan, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Quantitative proteomic analysis reveals the effects of mu opioid agonists on HT22 cells
Yazar:: Xutong Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Monitoring endogenous GPCRs: lessons for drug design
Yazar:: Dominique Massotte
Baskı/Yayın Bilgisi: (2015)

DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion
Yazar:: Chidambaran V, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

OA08.02. Differential acute effects of real and sham acupuncture on mu-opioid receptor availability in treatment naive and conditioned chronic pain patients
Yazar:: Akbar N, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine
Yazar:: Leana J. Pande, ve diğerleri
Baskı/Yayın Bilgisi: (2023)